KEGG   DRUG: Bictegravir - embitcitabine - tenofovir alafenamide mixtHelp
Entry
D11039            Mixture   Drug                                   

Name
Bictegravir - embitcitabine - tenofovir alafenamide mixt;
Biktarvy (TN)
Product
Component
(Bictegravir [DR:D10909] | Bictegravir sodium [DR:D10910]), Emtricitabine [DR:D01199], (Tenofovir alafenamide [DR:D10428] | Tenofovir alafenamide fumarate [DR:D10605])
Remark
Product: D11039<US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Brite
Antiinfectives [br08350.html]
 Antivirals
  D11039
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D11039
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11039
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11039
BRITE hierarchy
Other DBs
PubChem: 354339134
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system